Handgretinger, R.
163  results:
Search for persons X
?
2

Targeting GD2 after allogeneic SCT: effector cell compositi..:

Arendt, A.-M. ; Heubach, F. ; Maier, C. P....
Cancer Immunology, Immunotherapy.  72 (2023)  11 - p. 3813-3824 , 2023
 
?
4

Targeting GD2 after allogeneic SCT: effector cell compositi..:

Arendt, A.-M ; Heubach, F ; Maier, C. P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576705/.  , 2023
 
?
5

A Prospective, Multicenter Study of Closed-System Extracorp..:

Kitko, Carrie L. ; Abdel-Azim, Hisham ; Carpenter, Paul A....
Transplantation and Cellular Therapy.  28 (2022)  5 - p. 261.e1-261.e7 , 2022
 
?
7

Haematopoietic stem cell transplantation for severe autoimm..:

Achini‐Gutzwiller, FR ; Snowden, JA ; Corbacioglu, S...
https://eprints.whiterose.ac.uk/190416/1/Br%20J%20Haematol%20-%202022%20-%20Achini%E2%80%90Gutzwiller%20-%20Haematopoietic%20stem%20cell%20transplantation%20for%20severe%20autoimmune%20diseases%20in.pdf.  , 2022
 
?
9

No difference in survival after HLA mismatched versus HLA m..:

Thiel, U. ; Schober, S. J. ; Ranft, A....
Bone Marrow Transplantation.  56 (2021)  7 - p. 1550-1557 , 2021
 
?
10

Correction to: No difference in survival after HLA mismatch..:

Thiel, U. ; Schober, S. J. ; Ranft, A....
Bone Marrow Transplantation.  56 (2021)  9 - p. 2320-2320 , 2021
 
?
13

No difference in survival after HLA mismatched versus HLA m..:

Thiel, U ; Schober, S. J ; Ranft, A...
Bone Marrow Transplantation -- 0268-3369 -- 1476-5365.  , 2021
 
?
14

Correction to: No difference in survival after HLA mismatch..:

Thiel, U ; Schober, S. J ; Ranft, A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410592/.  , 2021
 
1-15